# Comparative Effects of Autologous Serum, Umbilical Cord Blood-Derived Drops, and Platelet Lysate on Ocular Surface Parameters

> **NCT07551843** · PHASE1,PHASE2 · COMPLETED · sponsor: **G.Gennimatas General Hospital** · enrollment: 80 (actual)

## Conditions studied

- Dry Eye Disease (DED)

## Interventions

- **BIOLOGICAL:** Autologous serum eyedrops
- **BIOLOGICAL:** Autologous Platelet Lysate
- **BIOLOGICAL:** Umbilical Cord Blood Platelet Lysate

## Key facts

- **NCT ID:** NCT07551843
- **Lead sponsor:** G.Gennimatas General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-17
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2026-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07551843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07551843, "Comparative Effects of Autologous Serum, Umbilical Cord Blood-Derived Drops, and Platelet Lysate on Ocular Surface Parameters". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT07551843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*